PHASE II STUDY OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE INPATIENTS WITH A FIRST RECURRENCE OF GLIOBLASTOMA MULTIFORME

被引：0
|
作者：
Aoki, Tomokazu [1 ]
Ueba, Tetsuya [2 ]
Miyatake, Shin-Ichi [3 ]
Nozaki, Kazuhiko [4 ]
Arakawa, Yoshiki [5 ]
Miyamoto, Susumu [5 ]
Tsukahara, Tetsuya [1 ]
Matsutani, Masao [6 ]
机构：
[1] Kyoto Med Ctr, Kyoto, Japan
[2] Kochi Univ, Kochi 780, Japan
[3] Osaka Med Coll, Osaka, Japan
[4] Shiga Univ, Otsu, Shiga, Japan
[5] Kyoto Univ, Kyoto, Japan
[6] Saitama Med Univ, Saitama, Japan
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
10.1093/neuonc/nou237.5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AT-05
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme
    Francesconi, Alessandra B.
    Dupre, Simon
    Matos, Marco
    Martin, David
    Hughes, Brett G.
    Wyld, David K.
    Lickliter, Jason D.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (08) : 970 - 974
  • [22] PHASE-II STUDY OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
    HSIEH, RK
    CHANG, AYC
    BOROS, L
    ASBURY, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (06): : 509 - 513
  • [23] PHASE II STUDY OF PEMBROLIZUMAB PLUS SURVAXM FOR GLIOBLASTOMA AT FIRST RECURRENCE
    Ahluwalia, Manmeet
    Peereboom, David
    Rauf, Yasmeen
    Schilero, Cathy
    Ciolfi, Marci
    Ciesielski, Michael
    Fenstermaker, Robert
    NEURO-ONCOLOGY, 2020, 22 : 34 - 35
  • [24] PHASE-II TRIAL OF ETOPOSIDE, CARBOPLATIN, AND IFOSFAMIDE AS SALVAGE THERAPY IN ADVANCED OVARIAN-CARCINOMA
    BEDDOE, AM
    DOTTINO, PR
    COHEN, CJ
    MOUNT SINAI JOURNAL OF MEDICINE, 1993, 60 (04): : 311 - 316
  • [25] Phase II study of temozolamide in patients with glioblastoma multiforme
    Janinis, J
    Tsantila, A
    Samantas, E
    Aravantinos, G
    Sitaras, N
    Skarlos, D
    ANNALS OF ONCOLOGY, 1998, 9 : 181 - 181
  • [26] Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study
    Lassen, U
    Kristjansen, PEG
    Wagner, A
    Kostel-janetz, M
    Poulsen, HS
    JOURNAL OF NEURO-ONCOLOGY, 1999, 43 (02) : 161 - 166
  • [27] Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study
    Ulrik Lassen
    Paul E.G. Kristjansen
    Aase Wagner
    Michael Kosteljanetz
    Hans Skovgaard Poulsen
    Journal of Neuro-Oncology, 2003, 62 : 362 - 362
  • [28] Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study
    Stamatoullas, Aspasia
    Ghesquieres, Herve
    Feugier, Pierre
    Andre, Marc
    Le Bras, Fabien
    Gac, Anne-Claire
    Borel, Cecile
    Gastinne, Thomas
    Quittet, Philippe
    Morschhauser, Franck
    Ribrag, Vincent
    Guidez, Stephanie
    Nicolas-Virelizier, Emmanuelle
    Berriolo-Riedinger, Alina
    Vander Borght, Thierry
    Edeline, Veronique
    Brice, Pauline
    LEUKEMIA & LYMPHOMA, 2022, 63 (13) : 3063 - 3071
  • [29] Treatment of Newly Diagnosed Glioblastoma Multiforme with Carmustine, Cisplatin and Etoposide Followed by Radiotherapy. A Phase II Study
    Ulrik Lassen
    Paul E.G. Kristjansen
    Aase Wagner
    Michael Kostel-janetz
    Hans Skovgaard Poulsen
    Journal of Neuro-Oncology, 1999, 43 : 161 - 166
  • [30] A PHASE-I STUDY OF IFOSFAMIDE CARBOPLATIN ETOPOSIDE PACLITAXEL IN ADVANCED LUNG-CANCER
    STRAUSS, GM
    LYNCH, TJ
    ELIAS, AD
    JACOBS, C
    KWIATKOWSKI, DJ
    SHULMAN, LN
    CAREY, RW
    GROSSBARD, ML
    JAUSS, S
    SUGARBAKER, DJ
    SKARIN, AT
    SEMINARS IN ONCOLOGY, 1995, 22 (04) : 70 - 74
12345